Concepedia

Lanreotide Reduces the Volume of Polycystic Liver: A Randomized, Double-Blind, Placebo-Controlled Trial

Loes van Keimpema, Frederik Nevens, Ragna Vanslembrouck, Martijn G.H. van Oijen, Aswin L. Hoffmann, Helena M. Dekker, Robert A. de Man, Joost P.H. Drenth

Gastroenterology · 2009 · 256 citations · 29 references

Open access

Concepts

MedicinePharmacologyPharmacotherapyHepatologyChronic Liver DiseaseCirrhosisHepatic ImpairmentHepatic PathophysiologyLiver DiseaseMetabolic Liver DiseaseLiver MorphometryLiver Volume AssessmentPlacebo-controlled Efficacy AssessmentPolycystic Liver Disease

References

29

The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

John E. Ware, Cathy D. Sherbourne · PubMed · 1992 · 34K citations

Pharmacy, Health Sciences, Geriatric Assessment +16

The MOS 36-ltem Short-Form Health Survey (SF-36)

John E. Ware, Cathy D. Sherbourne · Medical Care · 1992 · 29.8K citations

Pharmacy, Health Policy, Geriatric Assessment +16

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

David Moher, Kenneth F. Schulz, Douglas G. Altman · The Lancet · 2001 · 5.4K citations · Full text

Public Health, Biostatistics, Health Sciences +12

Volume Progression in Polycystic Kidney Disease

Jared J. Grantham, Vicente E. Torres, Arlene B. Chapman et al. · New England Journal of Medicine · 2006 · 792 citations · Full text

Medicine, Nephrology, Radiology +16

Magnetic Resonance Imaging Evaluation of Hepatic Cysts in Early Autosomal-Dominant Polycystic Kidney Disease

Kyongtae T. Bae, Fang Zhu, Arlene B. Chapman et al. · Clinical Journal of the American Society of Nephrology · 2005 · 305 citations

Medicine, Nephrology, Radiology +17